Elez, M.; Misic, D.; Velikic, G.; Karajovic, J.; Atanaskovic, L.; Supic, G.
PD-L1/CD274 and miR-155/MIR155HG Genetic Variants as Prognostic and Risk Biomarkers in Diffuse Large B-Cell Lymphoma. Cancers 2026, 18, 469.
https://doi.org/10.3390/cancers18030469
AMA Style
Elez M, Misic D, Velikic G, Karajovic J, Atanaskovic L, Supic G.
PD-L1/CD274 and miR-155/MIR155HG Genetic Variants as Prognostic and Risk Biomarkers in Diffuse Large B-Cell Lymphoma. Cancers. 2026; 18(3):469.
https://doi.org/10.3390/cancers18030469
Chicago/Turabian Style
Elez, Marija, Debora Misic, Gordana Velikic, Jelena Karajovic, Lavinika Atanaskovic, and Gordana Supic.
2026. "PD-L1/CD274 and miR-155/MIR155HG Genetic Variants as Prognostic and Risk Biomarkers in Diffuse Large B-Cell Lymphoma" Cancers 18, no. 3: 469.
https://doi.org/10.3390/cancers18030469
APA Style
Elez, M., Misic, D., Velikic, G., Karajovic, J., Atanaskovic, L., & Supic, G.
(2026). PD-L1/CD274 and miR-155/MIR155HG Genetic Variants as Prognostic and Risk Biomarkers in Diffuse Large B-Cell Lymphoma. Cancers, 18(3), 469.
https://doi.org/10.3390/cancers18030469